RIGEL PHARMACEUTICALS INC

RIGL

RIGEL PHARMACEUTICALS INC

RIGL

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-22Shares Purchased (TTM):0Shares Sold (TTM):9,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:14,493,729Shares Outstanding:18,412,000Institutional Ownership Pct.:78.72%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	61	24	41	49	53	46	57	52	36	26	33	45
Short Term Investments	35	122	114	89	55	31	21	9	13	24	24	17
Accounts Receivable Net Current	56	50	52	46	40	42	42	31	29	28	31	24
Inventory Net	14	12	12	13	10	5	6	5	8	7	6	6
Prepaid Expense And Other Assets Current	20	26	22	19	17	23	10	10	9	9	6	3
Assets Current	186	234	240	215	175	147	135	106	95	92	99	95
Intangible Assets Net Including Goodwill	94	24	25	25	26	27	27	28	28	29	14	14
Property Plant And Equipment Net	-	-	0	0	0	0	0	0	0	0	0	0
Deferred Income Tax Assets Net	238	243	246	-	-	-	0	-	-	-	-	-
Operating Lease Right Of Use Asset	1	1	1	1	1	1	0	0	1	1	1	1
Other Assets Noncurrent	3	2	2	1	4	2	2	5	5	4	3	5
Assets	521	505	514	243	207	176	164	139	128	127	117	115
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	4	7	4	7	4	3	4	6	9	7	8
Employee Related Liabilities Current	9	6	12	10	8	6	10	8	6	5	9	8
Asset Acquisition Contingent Consideration Liabili…	0	5	5	5	5	-	0	5	15	15	-	-
Contract With Customer Refund Liability Current	28	28	28	30	30	28	26	22	19	16	16	15
Loans Payable Current	39	30	30	30	22	15	7	-	-	15	7	-
Contract With Customer Liability Current	-	-	1	1	1	1	1	1	1	1	1	1
Other Liabilities Current	-	-	11	-	-	-	12	-	-	1	4	5
Other Accrued Liabilities Current	8	10	11	9	9	7	12	10	6	5	5	5
Operating Lease Liability Current	1	1	1	1	1	0	0	0	1	1	1	1
Liabilities Current	96	89	99	94	87	67	63	54	59	73	53	48
Asset Acquisition Contingent Consideration Liabili…	-	-	0	-	-	5	5	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	0	1	1	1	0	-	-	0	0	0
Long Term Loans Payable	0	15	22	30	37	45	52	60	60	45	52	60
Other Liabilities Noncurrent	-	-	0	-	-	40	40	40	40	40	40	39
Liabilities	96	105	122	125	125	157	161	154	158	158	146	147
Stockholders Equity
Preferred Stock Value	-	-	0	-	-	-	0	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,423	1,414	1,414	1,409	1,401	1,397	1,393	1,390	1,387	1,384	1,379	1,376
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	-0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-997	-1,014	-1,023	-1,291	-1,319	-1,379	-1,390	-1,404	-1,417	-1,416	-1,408	-1,408
Stockholders Equity	425	400	391	118	82	19	3	-15	-30	-32	-29	-32
Liabilities And Stockholders Equity	521	505	514	243	207	176	164	139	128	127	117	115
Stockholders Equity Note Stock Split Conversion Ra…	-	-	-	-	-	-	-	-	0	-	-	-
Preferred Stock Par Or Stated Value Per Share	-	-	0.001	-	-	-	0.001	-	-	-	0.001	-
Preferred Stock Shares Authorized	-	-	10	-	-	-	10	-	-	-	10	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	-	-	0.001	-	-	-	0.001	-	-	-	0.001	-
Common Stock Shares Authorized	-	-	400	-	-	-	400	-	-	-	400	-
Common Stock Shares Issued	-	-	18	-	-	-	18	-	-	-	17	-
Shares Outstanding	-	-	18	-	-	-	18	-	-	-	17	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	8.54%	37.74%	30.79%	-	-	-	-	-	-	-	-	-
2025	5.15%	6.68%	10.46%	60.27%	18.11%	23.64%	77.91%	55.07%	30.23%	-21.84%	-8.27%	-12.14%
2024	-17.65%	-30.92%	-9.66%	44.05%	75.99%	51.77%	78.82%	6.87%	43.59%	-19.02%	-12.68%	-14.18%
2023	-	-	-	-	-	-	25.29%	66.67%	48.28%	0.00%	-25.68%	-38.51%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.94	2.62	2.42	2.28	2.02	2.20	2.13	1.96	1.62	1.26	1.86	1.97
Quick Ratio	1.58	2.20	2.08	1.94	1.71	1.78	1.88	1.69	1.33	1.05	1.64	1.78
Working Capital	89.94M	144.54M	140.93M	120.53M	88.76M	79.93M	71.80M	52.16M	36.07M	19.29M	46.00M	46.75M
Leverage & Debt
Debt to Equity	0.22	0.26	0.31	1.06	1.52	8.48	48.87	-10.53	-5.29	-4.99	-5.09	-4.62
Interest Coverage TTM	21.20	23.95	22.32	15.70	13.51	5.56	3.06	1.21	-1.17	-1.95	-2.98	-3.36
Debt Ratio	0.18	0.21	0.24	0.52	0.60	0.89	0.98	1.10	1.23	1.25	1.24	1.28
Efficiency & Turnover
Asset Turnover TTM	0.75	0.88	0.87	1.35	1.46	1.34	1.28	1.21	1.03	0.96	0.93	1.07
Days Sales Outstanding TTM	64.54	55.70	57.91	54.06	51.44	62.06	73.46	64.13	71.54	86.25	110.66	57.96
Receivables Turnover TTM	5.66	6.55	6.30	6.75	7.10	5.88	4.97	5.69	5.10	4.23	3.30	6.30
Per Share Metrics
Diluted EPS TTM	16.45	18.50	19.48	5.91	5.39	2.05	0.99	0.22	-0.81	-1.13	-1.44	-1.40
Free Cash Flow Per Share TTM	4.28	4.31	4.21	3.78	3.68	1.99	1.77	0.59	-0.72	-0.39	-1.19	-2.09
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	91.21%	93.39%	93.33%	92.47%	90.69%	89.64%	89.60%	89.19%	92.20%	93.22%	93.92%	97.02%
Operating Profit Margin TTM	32.09%	41.56%	42.63%	46.06%	42.84%	21.63%	13.49%	6.17%	-7.11%	-12.24%	-17.53%	-16.56%
Net Profit Margin TTM	118.65%	121.51%	124.72%	43.87%	40.07%	18.31%	9.75%	2.52%	-11.22%	-16.45%	-21.47%	-19.85%
Growth Metrics
Net Revenue Growth (1Y)	11.13%	47.61%	64.15%	67.70%	92.47%	68.74%	53.38%	25.18%	8.12%	-7.12%	-2.79%	-19.93%
Net Income Growth (1Y)	229.08%	879.70%	1,999.08%	2,819.35%	-787.33%	-287.75%	-169.69%	-115.89%	-62.32%	-55.66%	-57.16%	-70.43%
EPS Growth (1Y)	217.44%	847.56%	1,951.47%	2,748.46%	-774.42%	-284.71%	-168.98%	-115.74%	-62.74%	-56.08%	-57.56%	-70.69%
Valuation Metrics
P/E TTM	2.25	1.37	2.10	4.51	3.42	8.62	16.91	73.37	-10.14	-13.09	-10.06	-7.71
P/B TTM	1.70	1.24	1.97	4.35	4.09	17.25	89.93	-19.46	-4.82	-8.19	-8.81	-5.92
P/S TTM	2.67	1.66	2.62	1.98	1.37	1.58	1.65	1.85	1.14	2.15	2.16	1.53
Market Cap	725.32M	497.86M	770.38M	511.02M	334.99M	320.37M	295.68M	284.77M	144.25M	259.30M	252.31M	188.31M
Enterprise Value	703.69M	503.26M	759.56M	492.19M	303.88M	289.40M	246.20M	233.08M	108.20M	248.50M	226.76M	142.89M
Calculated Values
Free Cash Flow TTM	79.39M	79.27M	75.66M	68.18M	65.83M	35.37M	31.11M	10.37M	-12.67M	-6.82M	-20.74M	-36.49M
Net Debt	-21.64M	5.40M	-10.83M	-18.83M	-31.10M	-30.97M	-49.47M	-51.69M	-36.05M	-10.79M	-25.56M	-45.41M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Sale

Owner: Ali-Jackson, Kamil

Title: -

Shares: 2,500

Price/Share: $35.00

Value: $87,500.00

Shares Owned: 10,125

Relationship: Director

Ownership: Direct

2026-05-26Sale

Owner: Ali-Jackson, Kamil

Title: -

Shares: 2,500

Price/Share: $29.17

Value: $72,925.00

Shares Owned: 12,625

Relationship: Director

Ownership: Direct

2026-02-20Sale

Owner: Moos, Walter H

Title: -

Shares: 4,000

Price/Share: $36.36

Value: $145,440.00

Shares Owned: 12,722

Relationship: Director

Ownership: Direct

2025-02-05Sale

Owner: Schorno, Dean L

Title: EVP & Chief Financial Officer

Shares: 1,734

Price/Share: $21.93

Value: $38,026.62

Shares Owned: 57,235

Relationship: Officer

Ownership: Direct

2025-02-05Sale

Owner: Furey, Raymond J.

Title: EVP, GC, CCO & Corp Sec

Shares: 1,339

Price/Share: $21.93

Value: $29,364.27

Shares Owned: 38,830

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Ali-Jackson, Kamil	Director	-	Direct	Sale	2,500	35.00	$87,500.00	10,125	4
2026-05-26	Ali-Jackson, Kamil	Director	-	Direct	Sale	2,500	29.17	$72,925.00	12,625	4
2026-02-20	Moos, Walter H	Director	-	Direct	Sale	4,000	36.36	$145,440.00	12,722	4
2025-02-05	Schorno, Dean L	Officer	EVP & Chief Financial Officer	Direct	Sale	1,734	21.93	$38,026.62	57,235	4
2025-02-05	Furey, Raymond J.	Officer	EVP, GC, CCO & Corp Sec	Direct	Sale	1,339	21.93	$29,364.27	38,830	4
2025-02-05	Rodriguez, Raul R	Director,Officer	CEO, President	Direct	Sale	4,400	21.93	$96,492.00	239,454	4
2025-02-05	Santos, David A	Officer	EVP, Chief Commercial Officer	Direct	Sale	1,796	21.93	$39,386.28	51,704	4
2024-02-05	Santos, David A	Officer	EVP, Chief Commercial Officer	Direct	Sale	8,918	1.14	$10,166.52	349,093	4
2024-02-05	Rodriguez, Raul R	Director,Officer	CEO, President	Direct	Sale	30,545	1.14	$34,821.30	2,036,629	4
2024-02-02	Schorno, Dean L	Officer	EVP & Chief Financial Officer	Direct	Sale	5,601	1.13	$6,329.13	409,918	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.72%

Inst. Shares: 14,493,729

Shares Outstanding: 18,412,000

2025-12-31

82.77%

Inst. Shares: 14,887,180

Shares Outstanding: 17,987,000

2025-09-30

78.15%

Inst. Shares: 14,096,400

Shares Outstanding: 18,038,000

2025-06-30

72.02%

Inst. Shares: 12,880,403

Shares Outstanding: 17,885,000

2025-03-31

73.37%

Inst. Shares: 13,064,982

Shares Outstanding: 17,808,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	14,493,729	18,412,000	78.72%
2025-12-31	14,887,180	17,987,000	82.77%
2025-09-30	14,096,400	18,038,000	78.15%
2025-06-30	12,880,403	17,885,000	72.02%
2025-03-31	13,064,982	17,808,000	73.37%
2024-12-31	11,503,472	17,579,000	65.44%
2024-09-30	11,408,074	17,600,000	64.82%
2024-06-30	9,677,791	17,549,000	55.15%
2024-03-31	10,154,907	17,520,000	57.96%
2023-12-31	9,836,618	17,401,000	56.53%
2023-09-30	9,892,972	17,436,000	56.74%
2023-06-30	10,199,026	17,356,000	58.76%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

RIGEL PHARMACEUTICALS INC (RIGL) — SEC Financial Statements & Analysis

RIGEL PHARMACEUTICALS INC (RIGL) is a pharmaceutical preparations company, incorporated in DE. RIGEL PHARMACEUTICALS INC trades on Nasdaq as: RIGL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), RIGEL PHARMACEUTICALS INC reported a 11.13% year-over-year revenue growth, a Gross Profit Margin of 91.21% (TTM), a Debt-to-Equity ratio of 0.22x, a Price-to-Sales (P/S) ratio of 2.67x (TTM), a Price-to-Book (P/B) ratio of 1.70x (TTM), at a market cap of $725.32M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 11.13%
Gross Profit Margin TTM: 91.21%
Debt To Equity: 0.22x
P/S TTM: 2.67x
P/B TTM: 1.70x
Market Cap: $725.32M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RIGEL PHARMACEUTICALS INC in?

RIGEL PHARMACEUTICALS INC (RIGL) operates in the Pharmaceutical Preparations industry.

What is RIGL's market cap?

RIGEL PHARMACEUTICALS INC (RIGL) has a market capitalization of $725.32M as of 2026-06-30.

What is RIGL's P/E ratio?

RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month P/E ratio is 2.25x as of 2026-06-30.

What exchange does RIGL trade on?

RIGEL PHARMACEUTICALS INC (RIGL) trades on the Nasdaq.

Where is RIGEL PHARMACEUTICALS INC incorporated?

RIGEL PHARMACEUTICALS INC is incorporated in DE.